Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06087029 · ClinicalTrials.gov registry record · NA
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
A NA study of Type B Aortic Dissection, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,100
- Enrollment target
- 20
- Study locations
NCT06087029 is a NA study of Type B Aortic Dissection that is actively recruiting participants, run by Duke University. The registered enrollment target is 1,100 participants. The trial reports 20 study locations across 11 states.
The verdict
NCT06087029, a NA study of Type B Aortic Dissection, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,100 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with surveillance for deterioration in patients with uncomplicated type B aortic dissection.
Conditions Studied
Interventions
- PROCEDURE TEVAR
- OTHER Guideline directed medical therapy and surveillance of dissection
Study Locations (20)
California
- Memorial Care Long Beach Medical Center - Long Beach
- Keck Medical Center of USC - Los Angeles
- University of California San Diego - San Diego
- University of California - San Francisco
- Stanford University Medical Center - Stanford
Illinois
- Northwestern University - Chicago
- The University of Chicago - Chicago
- Southern Illinois University School of Medicine - Springfield
Colorado
- University of Colorado Denver - Aurora
- Memorial Hospital Central - Colorado Springs
Connecticut
- Hartford Hospital - Hartford
- Yale University - New Haven
Florida
- University of Florida Health - Gainesville
- Tampa General Hospital - Tampa
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Honorhealth - Phoenix
Indiana
- Indiana University Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,100 participants |
| Start Date | 2024-04-14 |
| Est. Completion | 2030-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06087029
The ClinicalTrials.gov registry entry for NCT06087029 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type B Aortic Dissection appearing as the primary indexed condition, and to 2 interventions - of which TEVAR is the first listed.
NCT06087029 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Illinois, Colorado.
Frequently Asked Questions
What is clinical trial NCT06087029 about?
NCT06087029 is a clinical study titled "IMPRoving Outcomes in Vascular DisEase - Aortic Dissection". The goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with surveillance for det...
What is the current status of trial NCT06087029?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,100 participants. The study started on 2024-04-14. Estimated completion is 2030-06-30.
What conditions does trial NCT06087029 study?
This clinical trial studies the following conditions: Type B Aortic Dissection.
What interventions are being tested in trial NCT06087029?
The interventions under investigation include: TEVAR (PROCEDURE), Guideline directed medical therapy and surveillance of dissection (OTHER).
Who is sponsoring clinical trial NCT06087029?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06087029 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.